This announcement is a separate document:
天坛生物：董事会关于重大资产出售及购买暨关联交易信息公布前公司股票价格波动未达到《关于规范上市公司信息披露及相关各方行为的通知》相关标准的说明
Tiantan Biotech: The Board's explanation that the company's stock price fluctuations did not meet the relevant standards of the “Notice on Regulating the Disclosure of Information Disclosure of Listed Companies and the Conduct of Related Parties” before th
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.